ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
CH
Centre Hospitalier de l’Université de Montréal at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Centre Hospitalier de l’Université de Montréal takes part in 4 sessions at ESMO 2026 in Madrid. Its work covers cancer risk assessment and treatment outcomes across several tumour types. It examines an AI method for assessing colon cancer risk and factors linked to distant spread in head and neck cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
CH Centre Hospitalier de l’Université de Montréal Montreal, Canada | |
University hospital in Montreal, Canada. | Poster Fri Oct 23 13:00–15:00 Validation of diasurv an AI-based algorithm for stage II colon risk stratification Gastrointestinal cancers Poster Fri Oct 23 15:15–16:00 Prostate-specific antigen (PSA) endpoints with exploratory gene by gene subgroups in homologous recombination repair (HRR) gene–altered metastatic castration-sensitive prostate cancer (mCSPC) from TALAPRO-3 Genitourinary cancersBiomarkers & precision oncology Poster Sat Oct 24 12:00–12:45 Poster Mon Oct 26 12:00–12:45 Preoperative clinical predictors of distant metastasis in locally advanced head and neck squamous cell carcinoma: Risk stratification for perioperative immunotherapy Sarcoma, CNS, head & neck and rare cancers |
Find decision makers at Centre Hospitalier de l’Université de Montréal
Tell us what you sell and we’ll find the people at Centre Hospitalier de l’Université de Montréal most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction